1. The route to Government funding
My team is responsible for delivery the BMC, SBRI and Investor relations activities across Health and Life sciences.
Ran a few SBRI but largely funded through NHSE the SBRI Healthcare programme. Have slides about the others
Dr Cynthia Bullock
Senior Innovation Lead – Enabling Programmes
Innovate UK
HealthTech
Cardiff, Dec 2018

2. UK Research & Innovation
UK Research and Innovation combines Innovate UK with the Research Councils and Research England
UKRI is a new body which works in partnership to create the best possible environment for research and innovation to flourish in the UK
We have the opportunity to bring under one roof the very best of UK research and innovation, to push knowledge frontiers, to pull through the research that business wants and needs and to deliver both societal and economic impact for the good of the country.

3. We can’t stop thinking about the future
The UK’s innovation agency
Innovate UK drives productivity and growth by supporting businesses to realise the potential of new technologies, develop ideas and make them a commercial success.
Innovate UK’s mission – growth, productivity, jobs, exports.
We fund and connect business led innovation to realise their commercial value which helps accelerate the UK economy.
We can’t stop thinking about the future
To stay competitive as an advanced economy, we need to do things that others cannot do, or to do things in different and better ways.

4. We have invested £2.2 billion to date
Matched with just over £1.5 billion from industry.
11,000 projects
8,000 organisations
70,000 jobs created
And a return on investment of up to £7.30 for every £1 invested.
This is public money and we take it very seriously, regularly analysing our portfolio for the impact achieved.

5. Connect Thematic Focus Knowledge Transfer Advisors
Local Presence Global Connections

6. Catapults
We also fund infrastructure called Catapults which aims to bring together the excellent UK research base and innovative businesses in specific areas where the UK has world class expertise.

7. Innovate UK Fund Portfolio
financing growth of innovative firms
Transforming existing industries & creating new ones
Through building new value chains
Through scaling high growth businesses
Challenge
Programmes
ISCF
Responsive
Programmes
Sectors
Open
Investor
Partnership
Matched
Equity
Responsive
Programmes
Innovation
Loans
Keynote: Identifying and driving innovation in UK industry
Opportunity Centric
Investments
Business Centric
Investments

8. Creating an economy that boosts productivity and earning power throughout the UK

9. Industrial Strategy Grand Challenges
AI and Data Economy
Ageing Society
Clean Growth
Future of Mobility

10. How the ISCF challenges fit with the
Industrial Strategy Grand Challenges
Clean growth
Energy revolution
Transforming construction
Transforming
food production
Ageing Society
Medicines manufacturing
Data to early diagnosis and precision medicine
Healthy ageing
Future of mobility
Faraday battery challenge
Extreme robotics
National space test facility
Artificial intelligence and data economy
Audience of the future / Next generation services (pioneer) / Quantum technology (pioneer)
The Industrial Strategy Challenge Fund (ISCF) is part of government’s Industrial Strategy.
UK Research and Innovation, business and the public sector are being encouraged to work in partnership to address four grand challenges

11. Underpinning UKRI investments (Wave 1a) up to £283m
Wave 1 Challenges (c. £1b)
Leading-Edge Healthcare Challenge
(including Medicines Mfg)
up to £188m
Faraday Battery Challenge
up to £246m
Robotics and AI in extreme environments
Challenge
up to £93m
Next Gen. Affordable Lightweight Materials Mfg (ATI projects) up to £26m
Autonomous Vehicles (CCAV projects)
up to £38m
National Satellite Test Facility
up to £99m
Underpinning UKRI investments (Wave 1a) up to £283m

12. Wave 2 Challenges (up to £729.5m)
Data to early diagnosis and precision medicine (up to £210m)
Prospering from the energy revolution
(up to £102.5m)
Audience of the future (up to £33m)
Healthy ageing
(up to £98m)
Next generation services (up to£20m)
Quantum technology (up to £20m)
Transforming construction
(up to £170m)
Transforming food production (up to £90m)

13. Submitted for Wave 3 support – Ageing Society
Early Detection of Disease - Building a well-characterised, longitudinal cohort of participants who are not yet exhibiting symptoms of disease
Developing innovative nutritional products & services for healthier ageing
Reimagining our Neighbourhoods of the Future to support health and wellbeing

14. Open competitions UK based business (any size)
UK project and exploitation
Alone or in collaboration with businesses/research/charities
be an SME if you want to work alone/include an SME if you want to collaborate with others
Game changing/disruptive
RTO can lead also
Project duration between 6 and 18 months: total costs must be between £25,000 and £500,000 and may be either single company or collaborative applications.
Project duration between 19 and 36 months: total costs must be between £25,000 and £2,000,000 and must be collaborative.

15. Biomedical Catalyst funding streams

16. De-risked, high potential deals Grow UK’s Knowledge Economy
Investment Accelerator Maximising Impact & Minimising Risk in Partnership
ROI
Business scalability
De-risked, high potential deals
Recycle public purse
Grow UK’s Knowledge Economy
Innovative
technology
Commercial opportunity ✔ ✔
High
risk
Investable people
Start: innovate UK identifies novel/disruptive/innovative technologies and uses our funding to change the risk profile to allow investors to invest earlier/wider
Build 1: in parallel investors look at the commercial potential and identify the best quality teams
Build 2: it is only when companies achieve simultaneous success in both of these independent processes that companies receive innovate UK grant alongside equity investment
Build 3: ROI is created through balancing risk and reward for all:
a) direct to companies by linking them into a runway of finance
b) a pipeline of high quality deals for investors
c) enables innovate UK to drive the UK knowledge economy and
d) creates a mechanism to recycle UK investment through GVA measures
Work to secure a specific budget is ongoing ✔ ✔

17. Affordable, flexible and patient
Innovation Loans
Affordable, flexible and patient 10
3.7%
years
Single Applicant
SMEs only
Our innovation loans programme was specifically developed to be affordable, flexible and patient
Complimentary not a replacement to R&D grants. Supports R&D developments that are closer to market, Requires project/technology and business evaluation
Loan structured for project and commercial success
Availability period (up to 3 years)
Extension period (up to 2 years)
Repayment period (up to 5 years)
Up to 100% of
project costs
Later stage R&D
Low interest
rate
Flexible & patient
Up to 10 years
Loan size
£100k to £1m
#innovationloans

18. Current Competitions
SME support to evaluate innovative medical technologies: round 3 - £1.5 million, Closes 30 January 2019

19. Find out more: https://www.gov.uk/government/organisations/innovate-uk
Customer Support Service
Phone: (Mon-Fri, 9am-5:30pm)